Top Story

Breast cancer incidence will increase by 50% by 2030

April 21, 2015

Read the Perspective from Louis M. Weiner, MD

PHILADELPHIA — The total number of invasive and in-situ breast cancer cases in the United States likely will increase 50% by 2030, according to study results presented at the American Association for Cancer Research Annual Meeting.

Increased incidence of ER-positive in-situ cancers, as well as a considerable increase in breast cancer cases among women aged 70 years or older, will account for much of the trend, results showed.

Meeting News CoveragePerspective

MPDL3280A shows promise in metastatic triple-negative breast cancer

April 20, 2015
PHILADELPHIA — The investigational immunotherapy MPDL3280A appeared well tolerated and demonstrated favorable efficacy in patients with metastatic triple-negative…
Stephen F Hodi Meeting News CoveragePerspective

Simultaneous treatment with ipilimumab, nivolumab improves outcomes in advanced melanoma

April 20, 2015
PHILADELPHIA — Patients with treatment-naive advanced melanoma who underwent simultaneous treatment with ipilimumab and nivolumab demonstrated longer PFS and a…

Yale launches personalized therapy trial for metastatic melanoma

April 20, 2015
Yale University announced recently that it has begun a multicenter clinical trial to apply personalized medicine technology to the treatment of metastatic melanoma.The…
Jedd Wolchok Meeting News Coverage

ACS, Stand Up To Cancer announce lung cancer research initiative

April 20, 2015
PHILADELPHIA — Stand Up to Cancer, or SU2C, and the American Cancer Society today announced the formation of a $20 million lung cancer “Dream Team”…
More News Headlines »
Hematology Oncology Case Consults

Diagnosis and Management of Hemophilia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of the patient with hemophilia supplemented with a case…
More »
Meeting News Coverage Video
VIDEO: Ongoing phase 3 trial evaluates patient-specific vaccine in metastatic melanoma

VIDEO: Ongoing phase 3 trial evaluates patient-specific vaccine in metastatic melanoma

April 12, 2015
Robert O. Dillman, MD, vice president of oncology at NeoStem Inc., provides an overview of a phase 3 trial evaluating…
More »
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »